Ignite Creation Date:
2025-12-24 @ 9:17 PM
Ignite Modification Date:
2025-12-30 @ 7:46 PM
Study NCT ID:
NCT04342104
Status:
UNKNOWN
Last Update Posted:
2021-08-30
First Post:
2020-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure
Sponsor:
Hospital General Universitario Morales Meseguer
Organization:
Study Overview
Official Title:
NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure
Status:
UNKNOWN
Status Verified Date:
2021-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure.
Propose adaptations to HACOR score based on the "state of art" of COVID-19
Propose adaptations to HACOR score based on the "state of art" of COVID-19
Detailed Description:
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure.
Propose adaptations to HACOR score based on the "state of art" of COVID-19
\- this adaptations may include radiologic aggravation and monitoring of CRF, ferritin, LDH, d-dimers, NT-proBNP, troponin I, GOT, GPT, blood count
Propose adaptations to HACOR score based on the "state of art" of COVID-19
\- this adaptations may include radiologic aggravation and monitoring of CRF, ferritin, LDH, d-dimers, NT-proBNP, troponin I, GOT, GPT, blood count
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: